Expertise in
15
conditions
Expertise in
15
conditions
Siu Medicine Pediatrics
400 N 9th St, 
Springfield, IL 

Overview

Gregory Brandt is a Pediatrics provider in Springfield, Illinois. Dr. Brandt is highly rated in 15 conditions, according to our data. His top areas of expertise are Rhabdoid Tumor, Hepatoblastoma, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 50 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in IL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Siu Medicine Pediatrics
400 N 9th St, Springfield, IL 62702

Additional Areas of Focus

Dr. Brandt has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


50 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 49 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions

Siu Medicine Urology | HSHS St. John's Pavilion

301 N 8th St Ste 3B-100, 
Springfield, IL 
 (0.4 miles away)
Languages Spoken:
English

Ranjiv Mathews is a Pediatrics provider in Springfield, Illinois. Dr. Mathews is highly rated in 9 conditions, according to our data. His top areas of expertise are Urinary Tract Infection in Children, Reflux Nephropathy, Exstrophy of the Bladder, Osteotomy, and Bladder Reconstruction.

Expertise in
8
conditions
Pediatrics
Expertise in
8
conditions
Pediatrics

Children's Medical Group Pediatric Surgery

420 NE Glen Oak Ave, 
Peoria, IL 
 (62.0 miles away)
Languages Spoken:
English

Paul Noh is a Pediatrics provider in Peoria, Illinois. Dr. Noh is highly rated in 8 conditions, according to our data. His top areas of expertise are Congenital Giant Megaureter, Undescended Testicle, Hydronephrosis, Endoscopy, and Lithotripsy.

Expertise in
28
conditions
Neonatology | Pediatrics
Expertise in
28
conditions
Neonatology | Pediatrics

Osf Saint Francis-Radiation Oncology

530 NE Glen Oak Ave, 
Peoria, IL 
 (62.0 miles away)
Languages Spoken:
English

Praveen Kumar is a Neonatologist and a Pediatrics provider in Peoria, Illinois. Dr. Kumar is highly rated in 28 conditions, according to our data. His top areas of expertise are Malnutrition, Neonatal Sepsis, Premature Infant, Parathyroidectomy, and Cataract Removal.

Frequently Asked Questions about Dr. Gregory Brandt

How do I make an appointment with Dr. Gregory Brandt?

You can book an appointment with Dr. Gregory Brandt by calling their office at 217-545-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gregory Brandt a top-rated expert for Rhabdoid Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory Brandt is classified as an Advanced expert for Rhabdoid Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gregory Brandt specialize in?

While Dr. Gregory Brandt is a Pediatrics, they have specific expertise in Rhabdoid Tumor, Hepatoblastoma, and Reticulohistiocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Gregory Brandt participate in research or clinical trials?

Yes. Dr. Gregory Brandt has published 1 articles and abstracts on conditions like Rhabdoid Tumor. You can view a list of Dr. Gregory Brandt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gregory Brandt accept my insurance?

Dr. Gregory Brandt accepts most major insurance plans, including Aetna and Health Alliance. We recommend calling the office directly at 217-545-8000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brandt's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile